SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 835.43 |
Enterprise Value ($M) | 703.25 |
Book Value ($M) | 120.26 |
Book Value / Share | 1.42 |
Price / Book | 6.95 |
NCAV ($M) | 120.26 |
NCAV / Share | 1.42 |
Price / NCAV | 6.95 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.36 |
Return on Assets (ROA) | -0.29 |
Return on Equity (ROE) | -0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.86 |
Current Ratio | 8.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 135.57 |
Assets | 135.57 |
Liabilities | 15.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -50.59 |
Net Income | -43.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -30.81 |
Cash from Investing | 0.00 |
Cash from Financing | 11.97 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 5.31 | 5.22 | |
13G/A | BlackRock, Inc. | 8.10 | 19.59 | |
13G/A | State Street Corp | 4.44 | -37.33 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
309,690 | 1,029,667 | 30.08 | |
268,603 | 1,386,662 | 19.37 | |
589,372 | 2,761,422 | 21.34 | |
(click for more detail) |
Similar Companies | |
---|---|
ATHA – Athira Pharma, Inc. | ATRA – Atara Biotherapeutics, Inc. |
AVIR – Atea Pharmaceuticals, Inc. | BBIO – BridgeBio Pharma, Inc. |
BCRX – BioCryst Pharmaceuticals, Inc. |